Deutsche Bank’s Axcella Health Inc. Common Stock AXLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-384
Closed -$46K 4873
2021
Q1
$46K Sell
384
-38
-9% -$5.36K ﹤0.01% 4255
2020
Q4
$55K Buy
422
+93
+28% +$11.9K ﹤0.01% 4093
2020
Q3
$38K Buy
329
+125
+61% +$15.4K ﹤0.01% 3989
2020
Q2
$28K Buy
204
+106
+108% +$13K ﹤0.01% 4002
2020
Q1
$8K Sell
98
-7
-7% -$717 ﹤0.01% 4092
2019
Q4
$10K Buy
105
+88
+518% +$9.67K ﹤0.01% 4502
2019
Q3
$2K Sell
17
-32
-65% -$5.93K ﹤0.01% 4789
2019
Q2
$11K Buy
+49
New +$15.5K ﹤0.01% 4963

Other funds holding AXLA

Deutsche Bank's AXLA Position: Q2 2021 in Review

Deutsche Bank sold out of Axcella Health Inc. Common Stock (AXLA) in Q2 2021, closing a stake of 384 shares — an estimated $46K sold.

Deutsche Bank first reported a position in AXLA in Q2 2019 and held it in 8 quarters. The position peaked at $55K in Q4 2020. 38 funds tracked by Wall St. Rank hold AXLA as of Q2 2021.

  • Deutsche Bank reported no remaining Axcella Health Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Deutsche Bank sold 384 Axcella Health Inc. Common Stock shares in Q2 2021, an estimated $46K.
  • Deutsche Bank first reported a position in Axcella Health Inc. Common Stock in Q2 2019 and held it in 8 quarters.
  • Deutsche Bank's Axcella Health Inc. Common Stock position peaked at $55K in Q4 2020.
  • 38 funds tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q2 2021.

Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.